Skip to main content
. 2017 Sep 1;10(9):1117–1128. doi: 10.1242/dmm.029801

Fig. 6.

Fig. 6.

Activation of L1-mediated intracellular signaling cascades at 6 weeks after SCI in mice treated with trimebutine or honokiol. Western blot analysis of L1 (A), phosphorylation levels of Akt1 (B), Erk1/2 (C), CK2α (D) and mTOR (E), protein levels of PTEN (F), p53 (G) and GFAP (H), and Bcl-2/Bax ratio (I) of mice treated with vehicle control (VC), trimebutine (TMB) or honokiol (HNK) at 5 mm rostral to the lesion center, the lesion center, and 5 mm caudal to the lesion center. *P<0.05, **P<0.01 versus the vehicle control; one-way ANOVA with Tukey's post hoc test; n=4 mice/group.